Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 22521339)

1.

Muscle on a chip: in vitro contractility assays for smooth and striated muscle.

Grosberg A, Nesmith AP, Goss JA, Brigham MD, McCain ML, Parker KK.

J Pharmacol Toxicol Methods. 2012 May-Jun;65(3):126-35. doi: 10.1016/j.vascn.2012.04.001. Epub 2012 Apr 12.

2.

Vascular smooth muscle contractility depends on cell shape.

Alford PW, Nesmith AP, Seywerd JN, Grosberg A, Parker KK.

Integr Biol (Camb). 2011 Nov;3(11):1063-70. doi: 10.1039/c1ib00061f. Epub 2011 Oct 12.

PMID:
21993765
3.

Biohybrid thin films for measuring contractility in engineered cardiovascular muscle.

Alford PW, Feinberg AW, Sheehy SP, Parker KK.

Biomaterials. 2010 May;31(13):3613-21. doi: 10.1016/j.biomaterials.2010.01.079. Epub 2010 Feb 9.

4.

Microfluidic heart on a chip for higher throughput pharmacological studies.

Agarwal A, Goss JA, Cho A, McCain ML, Parker KK.

Lab Chip. 2013 Sep 21;13(18):3599-608. doi: 10.1039/c3lc50350j.

5.

Optimizing the structure and contractility of engineered skeletal muscle thin films.

Sun Y, Duffy R, Lee A, Feinberg AW.

Acta Biomater. 2013 Aug;9(8):7885-94. doi: 10.1016/j.actbio.2013.04.036. Epub 2013 Apr 28.

PMID:
23632372
6.

Drug-screening platform based on the contractility of tissue-engineered muscle.

Vandenburgh H, Shansky J, Benesch-Lee F, Barbata V, Reid J, Thorrez L, Valentini R, Crawford G.

Muscle Nerve. 2008 Apr;37(4):438-47. doi: 10.1002/mus.20931.

PMID:
18236465
7.

Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip.

Grosberg A, Alford PW, McCain ML, Parker KK.

Lab Chip. 2011 Dec 21;11(24):4165-73. doi: 10.1039/c1lc20557a. Epub 2011 Nov 10.

8.

The contractile strength of vascular smooth muscle myocytes is shape dependent.

Ye GJ, Aratyn-Schaus Y, Nesmith AP, Pasqualini FS, Alford PW, Parker KK.

Integr Biol (Camb). 2014 Feb;6(2):152-63. doi: 10.1039/c3ib40230d.

PMID:
24406783
9.

Long-term vascular contractility assay using genipin-modified muscular thin films.

Hald ES, Steucke KE, Reeves JA, Win Z, Alford PW.

Biofabrication. 2014 Sep 23;6(4):045005. doi: 10.1088/1758-5082/6/4/045005.

PMID:
25245868
10.

Homologous muscle acellular matrix seeded with autologous myoblasts as a tissue-engineering approach to abdominal wall-defect repair.

Conconi MT, De Coppi P, Bellini S, Zara G, Sabatti M, Marzaro M, Zanon GF, Gamba PG, Parnigotto PP, Nussdorfer GG.

Biomaterials. 2005 May;26(15):2567-74.

PMID:
15585259
11.

Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.

Yang D, Guo T, Nie C, Morris SF.

Ann Plast Surg. 2009 Mar;62(3):297-303. doi: 10.1097/SAP.0b013e318197eb19.

PMID:
19240529
12.

Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin.

Kang S, Woo HH, Kim K, Lim KM, Noh JY, Lee MY, Bae YM, Bae ON, Chung JH.

Toxicol Sci. 2014 Apr;138(2):446-556. doi: 10.1093/toxsci/kfu011. Epub 2014 Jan 21.

13.

Endomorphin-1 and -2, endogenous ligands for the mu-opioid receptor, inhibit striated and smooth muscle contraction in the rat oesophagus.

Storr M, Geisler F, Neuhuber WL, Schusdziarra V, Allescher HD.

Neurogastroenterol Motil. 2000 Oct;12(5):441-8.

PMID:
11012944
14.

Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds.

Jeong SI, Kwon JH, Lim JI, Cho SW, Jung Y, Sung WJ, Kim SH, Kim YH, Lee YM, Kim BS, Choi CY, Kim SJ.

Biomaterials. 2005 Apr;26(12):1405-11.

PMID:
15482828
15.

Microfilaments in cellular and developmental processes.

Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamada K.

Science. 1971 Jan 15;171(3967):135-43.

PMID:
5538822
16.

Phenotypic screening for pharmaceuticals using tissue constructs.

Wakatsuki T, Fee JA, Elson EL.

Curr Pharm Biotechnol. 2004 Apr;5(2):181-9. Review.

PMID:
15078152
17.

Vascular smooth muscle contractility assays for inflammatory and immunological mediators.

Marceau F, deBlois D, Petitclerc E, Levesque L, Drapeau G, Audet R, Godin D, Larrivée JF, Houle S, Sabourin T, Fortin JP, Morissette G, Gera L, Bawolak MT, Koumbadinga GA, Bouthillier J.

Int Immunopharmacol. 2010 Nov;10(11):1344-53. doi: 10.1016/j.intimp.2010.08.016. Epub 2010 Sep 8. Review.

PMID:
20831918
18.

Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture.

Feinberg AW, Alford PW, Jin H, Ripplinger CM, Werdich AA, Sheehy SP, Grosberg A, Parker KK.

Biomaterials. 2012 Aug;33(23):5732-41. doi: 10.1016/j.biomaterials.2012.04.043. Epub 2012 May 15.

19.

Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.

Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.

Arzneimittelforschung. 1996 Jan;46(1):15-24.

PMID:
8821512
20.

Regulation of vascular and gastric smooth muscle contractility by pervanadate.

Laniyonu A, Saifeddine M, Ahmad S, Hollenberg MD.

Br J Pharmacol. 1994 Oct;113(2):403-10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk